Although not typical of all the important studies, Kim et al., in a retrospective study involving tissue microarray blocks of 643 cases of invasive breast carcinomas, have found that the CD44+/CD24- marker was taken as a positive prognostic subgroup in breast neoplasm [32]. Here, CD44 is linked to invasive breast carcinoma.